Search Orphan Drug Designations and Approvals
-
Generic Name: | interleukin mutein fused to the C-terminus of an immunoglobulin G Fc domain by way of a G4S linker |
---|---|
Date Designated: | 03/23/2020 |
Orphan Designation: | Treatment of Graft-Versus-Host-Disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amgen Inc. 1 Amgen Center Drive Thousand Oaks, California 91320 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-